FB
FREYR Battery, Inc. /DE/ (FREY)·Q1 2024 Earnings Summary
Executive Summary
- FREYR reported a net loss of $28.5M and diluted EPS of $(0.20) for Q1 2024; cash, cash equivalents and restricted cash were $252.8M with no debt .
- Management reaffirmed the near-term milestone to commence automated unit cell production at the CQP in H1 2024, adding specificity to target initial volume production in Q2 2024; conventional technology licensing for Giga America is targeted for announcement in Q2 2024 .
- Sequential cash discipline improved: total cash uses fell to $23M vs $52M in Q4 2023 and $88M in Q1 2023, with gross capex of ~$21M largely offset by $19M contractor reimbursement; cash runway “well beyond” two years remains the focus .
- Key catalysts: proof of automated unit cell production at the CQP, announcement of a conventional tech agreement and offtakes, and DOE Title 17 conditional commitment targeted by year-end 2024 .
What Went Well and What Went Wrong
What Went Well
- Approaching first automated unit cell production using the SemiSolid Casting and Unit Cell Assembly at the CQP remains on track for H1 2024; management added a Q2 timeline for initial volume production to harvest data and quality evaluations .
- Strengthened Board alignment and capital formation capabilities with appointments of founding investors Todd Kantor and Tore Ivar Slettemoen, and David Manners; insiders’ collective ownership exceeds 20% per slides .
- Improved cash discipline: Q1 cash uses of $23M vs $52M in Q4 2023 and $88M in Q1 2023; gross capex of $21M offset by $19M reimbursement; headcount cut by 20% and contractors by 50% vs Nov 2023 .
Management quotes:
- “We expect to move from an aspiring battery company to a battery-producing company… later this quarter.” – Executive Chair Tom‑Einar Jensen .
- “We continue to expect that the first unit cell production trial… will take place in Q2 2024.” – CEO Birger Steen .
- “Ended Q1 2024 with $253 million of cash and no debt.” – CFO Oscar Brown .
What Went Wrong
- Continued complexity at the CQP: final tuning of the multi-carrier system (MCS) to merge cathode/anode/separator at precision tolerances remains outstanding, delaying verification of fully automated production; however, cathode/anode casting achieved and early hand-merge tests are “encouraging” .
- Q1 net loss widened YoY to $28.5M vs $12.7M; diluted EPS fell to $(0.20) vs $(0.09) prior year, driven in part by lower foreign currency gains YoY and higher R&D tied to commissioning .
- Estimates visibility: consensus estimates could not be sourced via S&P Global (mapping unavailable), limiting external benchmark comparisons this quarter [GetEstimates error].
Financial Results
Additional detail:
- No product revenues reported; statements present operating expenses and loss from operations with no revenue line items .
- Warrant liability fair value adjustment Q1: $0.146M gain vs $8.515M gain in Q4 2023 .
KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We… expect to move from an aspiring battery company to a battery-producing company… later this quarter.” – Tom‑Einar Jensen .
- “We continue to expect that the first unit cell production trial… will take place in Q2 2024.” – Birger Steen .
- “Ended Q1 2024 with $253 million of cash and no debt… seek opportunities to reduce unnecessary costs… extend our liquidity runway beyond the 2-year target.” – Oscar Brown .
- “A conventional technology track is likely the fastest pathway to market… IRA 45X production tax credits equate to $1–2 million per day of estimated benefit… at optimized production yields.” – Earnings slides .
- “We are approaching a major milestone… first unit cell production trial using the full automation… Casting and Unit Cell Assembly.” – Birger Steen .
Q&A Highlights
- CQP final steps: tuning the MCS to precisely merge cathode/anode/separator; management suggested “a few hours, a few days away” from first fully automated casted and merged cells, contingent on precision tuning .
- Downstream opportunity: focus on ESS customers adjacent to PV, with U.S. soil production offering supply-chain resilience over 10 years; Nidec partnership for modules/packs remains central .
- Growth initiative sourcing: most projects came from inbound interest given FREYR’s balance sheet and positioning; funnel approach with triage and screening .
- Guidance clarifications: initial unit cell production in Q2; conventional tech agreement expected Q2 with offtakes and financing refresh .
Estimates Context
- Wall Street consensus (S&P Global): EPS and revenue estimates for FREY Q1 2024 and prior quarters were unavailable due to missing SPGI mapping in our data connector (SpgiEstimatesError). As a result, no vs‑consensus comparison is provided this quarter [GetEstimates error].
- Implication: Without formal consensus, buyside should anchor near-term inflections on operational milestones (CQP automation, conventional licensing and offtakes, DOE Title 17 process) rather than EPS/Revenue beats/misses .
Key Takeaways for Investors
- CQP progress is the near-term swing factor: successful automated unit cell production in H1, with initial volume production in Q2, would materially de-risk technology and catalyze customer validation and capital formation; watch for formal updates from the CQP .
- Conventional tech track is a strategic hedge: licensing a mature platform can accelerate first revenues and leverage IRA economics while 24M scales; an agreement and offtake announcements are targeted for Q2 .
- Balance sheet strength supports optionality: $252.8M cash and no debt, with reduced burn and capex discipline, extends runway beyond 2 years, enabling non‑dilutive capital pursuit and project flexibility .
- Giga Arctic remains option value with potential monetization: no significant 2024 capex; unsolicited building sale inquiries; book value ~$225M—could be a funding lever depending on strategic choices .
- Structural ESS demand is strengthening: G7’s 1,500 GW target by 2030 and rising data‑center power needs (AI/crypto) align with FREYR’s ESS focus—supportive for offtake momentum once production plans firm .
- Near-term trading implications: stock likely reacts to discrete milestones—CQP automation proof, conventional agreement announcement, and DOE conditional commitment; delays or slippage vs Q2/H1 timelines would be negative, while firm offtakes and financing signals would be positive .
- Medium-term thesis: dual‑track technology strategy plus IRA economics can underpin a viable U.S. battery manufacturing footprint if execution at CQP and partner selection is timely; monitor margin potential and capex phasing as projects move toward FID .